John Hontz
About John Hontz
John Hontz serves as the Vice President of Pharmaceutical Sciences at Supernus Pharmaceuticals, Inc., a position he has held since 2015. He holds a Ph.D. in Pharmaceutics and an MBA, and has previously worked in senior roles at Biovail and CIMA Labs.
Work at Supernus Pharmaceuticals
John Hontz has served as the Vice President of Pharmaceutical Sciences at Supernus Pharmaceuticals, Inc. since 2015. In this role, he oversees the development and implementation of pharmaceutical strategies and initiatives. His leadership contributes to the advancement of the company's product pipeline and enhances its position in the pharmaceutical industry.
Education and Expertise
John Hontz holds a Bachelor's Degree in Pharmacy from the University of the Sciences in Philadelphia, where he studied from 1974 to 1979. He furthered his education by obtaining a Ph.D. in Pharmaceutics from the University of Maryland School of Pharmacy. Additionally, he earned an MBA from Duke University's Fuqua School of Business, equipping him with a strong foundation in both pharmaceutical sciences and business management.
Background
Before joining Supernus Pharmaceuticals, John Hontz held significant positions in the pharmaceutical sector. He was the Vice President of Pharmaceutical Sciences North America at Biovail from 2004 to 2011. Prior to that, he served as Chief Operating Officer at CIMA Labs from 1997 to 2004. His extensive experience spans various roles in pharmaceutical sciences, contributing to his expertise in the field.
Achievements
Throughout his career, John Hontz has held leadership roles that have influenced pharmaceutical development and operations. His tenure at Biovail and CIMA Labs involved overseeing critical projects and initiatives that advanced the companies' objectives in the pharmaceutical market. His contributions have been integral to the success of the organizations he has worked with.